Routine Babesia Treatment Fails. Relapse. Atovaquone Resistance.
Previous clinical study indicated Babesia infections can be refractory to drug treatment, and recrudescence or relapse of infection may occur after current treatment and can persist even for more than two years. In an immunodeficient mouse model, Lawres et al. have proved that current treatment with azithromycin up to 50 mg/kg, clindamycin up to 50 […]
Routine Babesia Treatment Fails. Relapse. Atovaquone Resistance. Read More »